HomeComparePCDVF vs MRK

PCDVF vs MRK: Dividend Comparison 2026

PCDVF yields 17.52% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCDVF wins by $22364873.80M in total portfolio value
10 years
PCDVF
PCDVF
● Live price
17.52%
Share price
$0.34
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22364873.86M
Annual income
$22,122,351,591,087.24
Full PCDVF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PCDVF vs MRK

📍 PCDVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCDVFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCDVF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCDVF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCDVF
Annual income on $10K today (after 15% tax)
$1,489.49/yr
After 10yr DRIP, annual income (after tax)
$18,803,998,852,424.15/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PCDVF beats the other by $18,803,998,844,095.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCDVF + MRK for your $10,000?

PCDVF: 50%MRK: 50%
100% MRK50/50100% PCDVF
Portfolio after 10yr
$11182436.96M
Annual income
$11,061,175,800,442.69/yr
Blended yield
98.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PCDVF
No analyst data
Altman Z
-0.1
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCDVF buys
0
MRK buys
0
No recent congressional trades found for PCDVF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCDVFMRK
Forward yield17.52%2.76%
Annual dividend / share$0.06$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$22364873.86M$56.8K
Annual income after 10y$22,122,351,591,087.24$9,798.13
Total dividends collected$22348699.17M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCDVF vs MRK ($10,000, DRIP)

YearPCDVF PortfolioPCDVF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,205$3,504.67$11,206$366.19+$3.0KPCDVF
2$24,504$9,305.18$12,650$502.35+$11.9KPCDVF
3$56,224$30,004.07$14,407$694.19+$41.8KPCDVF
4$188,837$128,678.02$16,585$967.82+$172.3KPCDVF
5$1,009,886$807,829.95$19,342$1,363.89+$990.5KPCDVF
6$9,155,732$8,075,154.39$22,913$1,947.19+$9.13MPCDVF
7$146,638,150$136,841,516.19$27,662$2,823.89+$146.61MPCDVF
8$4,253,450,251$4,096,547,430.88$34,159$4,173.35+$4253.42MPCDVF
9$226,656,322,702$222,105,130,933.80$43,337$6,308.80+$226656.28MPCDVF
10$22,364,873,856,379$22,122,351,591,087.24$56,776$9,798.13+$22364873.80MPCDVF

PCDVF vs MRK: Complete Analysis 2026

PCDVFStock

Pacific Century Regional Developments Limited, an investment holding company, provides business management and consultancy services. It has interests in the telecommunications, media, IT solutions, logistics, and property development and investment businesses in the Asia-Pacific region. The company was formerly known as Seapower Asia Investments Limited and changed its name to Pacific Century Regional Developments Limited in November 1994. The company was incorporated in 1963 and is headquartered in Singapore. Pacific Century Regional Developments Limited is a subsidiary of Pacific Century Group (Cayman Islands) Limited.

Full PCDVF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PCDVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCDVF vs SCHDPCDVF vs JEPIPCDVF vs OPCDVF vs KOPCDVF vs MAINPCDVF vs JNJPCDVF vs ABBVPCDVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.